Soliton Inc (NASDAQ:SOLY)’s share price traded up 5.3% during mid-day trading on Friday . The stock traded as high as $10.80 and last traded at $10.59, 205,621 shares were traded during trading. A decline of 77% from the average session volume of 910,472 shares. The stock had previously closed at $10.06.

Separately, ValuEngine lowered Soliton from a “buy” rating to a “hold” rating in a report on Tuesday, October 1st.

The firm has a fifty day moving average of $12.06 and a two-hundred day moving average of $12.78.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Tower Research Capital LLC TRC purchased a new position in shares of Soliton during the 2nd quarter valued at about $32,000. Bank of Montreal Can purchased a new position in shares of Soliton during the 2nd quarter valued at about $91,000. Royal Bank of Canada purchased a new position in shares of Soliton during the 2nd quarter valued at about $96,000. Morgan Stanley purchased a new position in shares of Soliton during the 2nd quarter valued at about $121,000. Finally, First Trust Advisors LP purchased a new position in shares of Soliton during the 3rd quarter valued at about $137,000. 3.54% of the stock is currently owned by institutional investors.

Soliton Company Profile (NASDAQ:SOLY)

Soliton, Inc, an early stage medical device company, focuses on developing and commercializing products using a proprietary rapid acoustic pulse technology platform. It offers a device for the removal of tattoos. The company was founded in 2012 and is headquartered in Houston, Texas.

Featured Story: What is the S&P 500 Index?

Receive News & Ratings for Soliton Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Soliton and related companies with MarketBeat.com's FREE daily email newsletter.